Professional Profile

Dr Jeremy Grummet

Dr Jeremy Grummet

Urologist

Urological surgeon at Alfred Health
MBBS, Master of Surgery, FRACS
Adjunct Clinical Associate Professor
Department of Surgery, Monash University
Member of Australian Urology Associates private practice group
EAU Guidelines Associate
Supervisor of Bachelor of Medical Science and Master of Surgery research students


PHILOSOPHY

Associate Professor Grummet believes that the best patient care can be delivered now and into the future by upholding the three pillars of surgery – clinical care, education and research – and that all three are best performed by the practising urological surgeon.


Assoc Prof Jeremy Grummet is a urological surgeon with specific training and expertise in urological cancers. He performs MRI-targeted transperineal biopsy for maximal accuracy and minimal risk in prostate cancer diagnosis. 

Assoc Prof Grummet also performs both robotic and open radical prostatectomy for the treatment of prostate cancer and is trained in brachytherapy (radioactive seed implantation). He performs laparoscopic (keyhole) surgery for kidney cancer and radical cystectomy (bladder removal) for locally aggressive bladder cancer.

In addition to his expertise in uro-oncology, Assoc Prof Grummet also treats a wide range of general urological problems, performing minimally invasive surgery for kidney stones (using laser), benign prostate disease, and vasectomy.

Assoc Prof Grummet completed his formal training in urology obtaining his FRACS in 2007.  The following year he completed a Clinical Uro-Oncology Fellowship under the supervision of Dr Martin Gleave at the Prostate Centre in Vancouver, Canada. During his Fellowship year he helped establish the robotic prostatectomy program at Vancouver General Hospital and completed a Robotic Surgery Mini-Residency at the University of California Irvine under Dr Thomas Ahlering.

He has presented widely at multiple national and international conferences on the benefits of surgery for high risk localised prostate cancer, and is a strong advocate of active surveillance for low risk prostate cancer to minimise unnecessary treatment.  He is a site investigator at Alfred Health on the PRIAS study, the largest worldwide study assessing outcomes for patients on active surveillance. 

Assoc Prof Grummet has extensive experience in performing transperineal biopsy for the diagnosis of prostate cancer and has run workshops teaching the technique to other urologists.  This technique provides excellent tissue sampling as well as a near-zero risk of serious infection. He conducts multiple clinical research projects on prostate cancer diagnostics and established the Victorian Transperineal Biopsy Collaboration (VTBC) research group in 2013. He also established the MRI Prostate Multidisciplinary Meeting at Epworth Healthcare in 2014. In 2017, Assoc Prof Grummet was an invited speaker in a plenary session debate on transperineal biopsy at the the American Urological Association's Annual Meeting in Boston, USA.

In 2016, Assoc Prof Grummet became the first non-European EAU (European Association of Urology) Guidelines Associate. The EAU Guidelines are renowned as the premier source of evidence-based guidelines for urological practice in the world, and are endorsed by USANZ.

As a proud member of Australian Urology Associates, Assoc Prof Grummet is involved in additional clinical research as an investigator in multi-centre trials including the assessment of:

- the therapeutic effect of Enzalutamide in newly diagnosed metastatic prostate cancer (ENZAMET)
- a decision aid for active surveillance of patients with low risk prostate cancer (ASTROID)
- lower urinary tract symptoms (LUTS) in patients with advanced prostate cancer
- sexual dysfunction in men on medical therapy for LUTS due to benign prostate enlargement.

In 2014, as a principal investigator on an ANZUP research team with oncologist Professor Ian Davis, Assoc Prof Grummet was awarded nearly $600,000 in competitive grant funding from Cancer Australia and the Prostate Cancer Foundation of Australia (PCFA) to conduct a multi-centre randomised control trial comparing different methods of pain relief for prostate biopsy, Painfree TRUS B.

Assoc Prof Grummet was a council member of Foundation 49 Men's Health group, and contributes regularly to educational material provided by Andrology Australia. Through the China-ANZ Project he has established an educational relationship with the Urology Department at Sir Run Run Shaw Hospital in Hangzhou, China. He has made several visits providing updates in the latest standard of urological care and speaks basic Mandarin.